Adoption of new therapies for patients with chronic inflammatory diseases

Our Research

The NIHR Birmingham Biomedical Research Centre in Inflammation is building on our established world-class strengths in inflammation biology and experimental medicine, and is accelerating access to and adoption of new therapies and diagnostic tests for patients with chronic immune-mediated inflammatory diseases (IMIDs).

The NIHR Birmingham Biomedical Research Centre has brought together three globally recognised and nationally funded research themes in inflammatory arthritis, inflammatory bowel disease and inflammatory sarcopenia and has created a first in class process-driven, pathway-focused approach to the study and management of inflammatory diseases.

Critical to the success of the three main research themes is our cross-cutting themes on Trial Design and Delivery, Devices and Diagnostic Tests and Entrepreneurship and Commercialisation.